RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey

      한글로보기

      https://www.riss.kr/link?id=A105341384

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: Severe asthma and asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) are difficult to control and are often associated with poor clinical outcomes. However, much is not understood regarding the diagnosis and treatment...

      Purpose: Severe asthma and asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) are difficult to control and are often associated with poor clinical outcomes. However, much is not understood regarding the diagnosis and treatment of severe asthma and ACOS. To evaluate the current perceptions of severe asthma and COPD among asthma and COPD specialists, we designed an e-mail and internet-based questionnaire survey. Methods: Subjects were selected based on clinical specialty from among the members of the Korean Academy of Asthma, Allergy and Clinical Immunology and the Korean Academy of Tuberculosis and Respiratory Diseases. Of 432 subjects who received an e-mail invitation to the survey, 95 subjects, including 58 allergists and 37 pulmonologists, responded and submitted their answers online. Results: The specialists estimated that the percentage of severe cases among total asthma patients in their practice was 13.9%±11.0%. Asthma aggravation by stepping down treatment was the most common subtype, followed by frequent exacerbation, uncontrolled asthma despite higher treatment steps, and serious exacerbation. ACOS was estimated to account for 20.7% of asthma, 38.0% of severe asthma, and 30.1% of COPD cases. A history of smoking, persistently low forced expiratory volume in 1 second (FEV1), and low FEV1 variation were most frequently classified as the major criteria for the diagnosis of ACOS among asthma patients. Among COPD patients, the highly selected major criteria for ACOS were high FEV1 variation, positive bronchodilator response, a personal history of allergies and positive airway hyperresponsiveness. Allergists and pulmonologists showed different assessments and opinions on asthma phenotyping, percentage, and diagnostic criteria for ACOS. Conclusions: Specialists had diverse perceptions and clinical practices regarding severe asthma and ACOS patients. This heterogeneity must be considered in future studies and strategy development for severe asthma and ACOS.

      더보기

      참고문헌 (Reference)

      1 Miravitlles M, "What pulmonologists think about the asthma-COPD overlap syndrome" 10 : 1321-1330, 2015

      2 Sin DD, "What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion" 48 : 664-673, 2016

      3 Gelb AF, "Unraveling the pathophysiology of the asthma-copd overlap syndrome: unsuspected mild centrilobular emphysema is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation" 148 : 313-320, 2015

      4 Bousquet J, "Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma" 126 : 926-938, 2010

      5 Wurst KE, "Understanding asthma-chronic obstructive pulmonary disease overlap syndrome" 110 : 1-11, 2016

      6 Reddel HK, "Treatment of overlapping asthma-chronic obstructive pulmonary disease: can guidelines contribute in an evidence-free zone?" 136 : 546-552, 2015

      7 Hekking PP, "The prevalence of severe refractory asthma" 135 : 896-902, 2015

      8 von Bulow A, "The prevalence of severe asthma and low asthma control among Danish adults" 2 : 759-767, 2014

      9 Gibson PG, "The overlap syndrome of asthma and COPD: what are its features and how important is it?" 64 : 728-735, 2009

      10 Perret JL, "The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age" 187 : 42-48, 2013

      1 Miravitlles M, "What pulmonologists think about the asthma-COPD overlap syndrome" 10 : 1321-1330, 2015

      2 Sin DD, "What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion" 48 : 664-673, 2016

      3 Gelb AF, "Unraveling the pathophysiology of the asthma-copd overlap syndrome: unsuspected mild centrilobular emphysema is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation" 148 : 313-320, 2015

      4 Bousquet J, "Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma" 126 : 926-938, 2010

      5 Wurst KE, "Understanding asthma-chronic obstructive pulmonary disease overlap syndrome" 110 : 1-11, 2016

      6 Reddel HK, "Treatment of overlapping asthma-chronic obstructive pulmonary disease: can guidelines contribute in an evidence-free zone?" 136 : 546-552, 2015

      7 Hekking PP, "The prevalence of severe refractory asthma" 135 : 896-902, 2015

      8 von Bulow A, "The prevalence of severe asthma and low asthma control among Danish adults" 2 : 759-767, 2014

      9 Gibson PG, "The overlap syndrome of asthma and COPD: what are its features and how important is it?" 64 : 728-735, 2009

      10 Perret JL, "The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age" 187 : 42-48, 2013

      11 O'Neill S, "The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry" 70 : 376-378, 2015

      12 Hardin M, "The clinical features of the overlap between COPD and asthma" 12 : 127-, 2011

      13 Louie S, "The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations" 6 : 197-219, 2013

      14 Bateman ED, "The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?" 3 : 719-728, 2015

      15 Zeki AA, "The asthma-COPD overlap syndrome: a common clinical problem in the elderly" 2011 : 2011

      16 Postma DS, "The asthma-COPD overlap syndrome" 373 : 1241-1249, 2015

      17 Chen H, "Subspecialty differences in asthma characteristics and management" 83 : 786-793, 2008

      18 Wenzel S, "Severe asthma: from characteristics to phenotypes to endotypes" 42 : 650-658, 2012

      19 Varsano S, "Severe and non-severe asthma in the community: a large electronic database analysis" 123 : 131-139, 2017

      20 Shaaban R, "Rhinitis and onset of asthma: a longitudinal population-based study" 372 : 1049-1057, 2008

      21 Francesco Menzella, "Real-life Efficacy of Omalizumab After 9 Years of Follow-up" 대한천식알레르기학회 9 (9): 368-372, 2017

      22 "Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society" 162 : 2341-2351, 2000

      23 이진국, "Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome" 대한내과학회 30 (30): 443-449, 2015

      24 Matteo Ferrando, "Personalized Medicine in Allergy" 대한천식알레르기학회 9 (9): 15-24, 2017

      25 Rhee CK, "Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma" 11 : 163-170, 2014

      26 Chung KF, "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma" 43 : 343-373, 2014

      27 Menezes AM, "Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma" 145 : 297-304, 2014

      28 Schatz M, "Improved asthma outcomes from allergy specialist care: a population-based cross-sectional analysis" 116 : 1307-1313, 2005

      29 Global Initiative for Chronic Obstructive Lung Disease (GOLD), "Global strategy for the diagnosis, management and prevention of COPD [Internet]" Global Initiative for Chronic Obstructive Lung Disease

      30 Global Initiative for Asthma (GINA), "Global strategy for asthma management and prevention [Internet]" Global Initiative for Asthma

      31 Kim TB, "Factors associated with severity and exacerbation of asthma: a baseline analysis of the cohort for reality and evolution of adult asthma in Korea (COREA)" 103 : 311-317, 2009

      32 Custovic A, "EAACI position statement on asthma exacerbations and severe asthma" 68 : 1520-1531, 2013

      33 Caminati M, "Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience" 16 : 128-, 2016

      34 Cazzola M, "Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome?" 138 : 977-983, 2016

      35 Chung KF, "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society" 13 : 1198-1208, 1999

      36 Jo YS, "Different prevalence and clinical characteristics of asthma-chronic obstructive pulmonary disease overlap syndrome according to accepted criteria" 118 : 696-703, 2017

      37 Kankaanranta H, "Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines" 116 : 291-307, 2015

      38 Merritt L. Fajt, "Development of New Therapies for Severe Asthma" 대한천식알레르기학회 9 (9): 3-14, 2017

      39 Soler-Cataluna JJ, "Consensus document on the overlap phenotype COPD-asthma in COPD" 48 : 331-337, 2012

      40 van Boven JF, "Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life" 149 : 1011-1020, 2016

      41 Lamprecht B, "COPD in never smokers: results from the population-based burden of obstructive lung disease study" 139 : 752-763, 2011

      42 Gibson PG, "Asthma-COPD overlap 2015: now we are six" 70 : 683-691, 2015

      43 Don D. Sin, "Asthma-COPD Overlap Syndrome: What We Know and What We Don’t" 대한결핵및호흡기학회 80 (80): 11-20, 2017

      44 Diaz-Guzman E, "Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population" 8 : 400-407, 2011

      45 Chung KF, "Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies" 279 : 192-204, 2016

      46 Lin TY, "Asthma phenotypes and endotypes" 19 : 18-23, 2013

      47 Ding B, "Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights" 10 : 363-371, 2016

      48 Sullivan SD, "Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients" 62 : 655-660, 2007

      49 Tkacova R, "Airway hyperresponsiveness in chronic obstructive pulmonary disease: a marker of asthma-chronic obstructive pulmonary disease overlap syndrome?" 138 : 1571-1579, 2016

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-10-01 평가 등재학술지 선정 (기타) KCI등재
      2012-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2011-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2010-07-14 학회명변경 한글명 : 대한알레르기학회 -> 대한천식알레르기학회
      영문명 : The Korean Academy Of Asthma And Allergy -> The Korean Academy of Asthma, Allergy and Clinical Immunology
      KCI등재후보
      2009-01-01 평가 SCOPUS 등재 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 2.43 0.8 1.86
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.55 1.38 0.89 0.15
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼